Our operating companies partner with you to address scientific challenges and deliver impact at every stage with a broad portfolio of solutions.
October 26 | 3pm-9pm
| Time | Type | Description | Room / Location | Presenter |
| TBD | Poster | A new approach for high-resolution full and empty AAV capsid analysis using a high-throughput method for comprehensive AAAV evaluation on a single CE platform
SCIEX | TBD | Stephen Lock |
| TBD | Poster | A single, ready-to-use kit for fast, comprehensive analysis of both plasmid topological isoforms and linear sizing on a multi-capillary electrophoresis platform
SCIEX | TBD | Stephen Lock |
| Time | Type | Description | Room / Location | Presenter |
| TBD | Poster | Application-driven optimization of tangential flow filtration for extracellular vesicle manufacturing
CYTIVA | TBD | Marion C |
| TBD | Poster | Design and development of an Integrated and Automatic automatic multi- step chromatography workflow for AAV purification.
CYTIVA | TBD | Asa/Hans Blom |
| TBD | Poster | From transient screening to stable production: a modular platform enabling accelerated, scalable and quality-driven AAV manufacturing
CYTIVA | TBD | Corinna Bialek; Cristina Alves Totoli e Silva; Keerthana Srinivasan; Martina Ruby; Daniel Hilbig; Judith Maas; Tanja Kahlau; Viktoria Mamontova; Simonas Staras; Kim Bogenrieder; Oliver Wartmann; Christian Niehus; Jona Drushku; Julia Mahlberg; Emmanuelle Cameau; Robert Whitfield |
| TBD | Poster | Next-generation AAV9 affinity resin for improved yield, speed, and scalability
CYTIVA | TBD | Ola Lind; Asa Hagner McWhirter; Helena Larkner; Andrea Negro; Gunther Reichenberger |
| TBD | Poster | A next-generation ionizable lipid LNP platform for efficient in vivo CAR T cell generation
CYTIVA | TBD | Martin Rabel |
| TBD | Poster | Scalable in vitro transcription using the WAVE 25 bioreactor system and Cytiva enzyme
CYTIVA | TBD | Shahin Heshmatifar |
| Time | Type | Description | Room / Location | Presenter |
| 14.00 - 16.00 | Scientific Talks | Multiplex Emperirical Off-targete Nomination using UNCOVERseq-pools
IDT | TBD | Andrea Sanchez-Pena |
| 13.30 - 14.30 | Scientific Talks | Solid tumors across modalities: Early decisions that shape the path to
Cytiva | Hall 3, Level 0 | Moderator: Emmanulle Cameau, Scientific Director Viral Vectors, Cytiva Panelists: Niels-Bjarne Woods Ph.D. Associate Professor, Lund Stem Cell Centre, Lund University, Sweden Chantal Lagresle , Senior Research Scientist, Imagine Institute for Genetic Diseases, Paris France Michael Krohn, Co-CEO & Co-Founder, Akribion Therapeutics, Frankfurt Germany |
| TBD | Poster | Accelerating Stable AAV Producer Cell Line Development Through AI-Driven Decision Intelligence
Cytiva | TBD | Jona Drushku; Michelle Hussong; Yanis Habtoun; Christian Niehus; Cristina Alves Totoli e Silva; Nicolas Hirioguen; Sara Cotineau |
| TBD | Poster | Redefining the Cost Equation for AAV Manufacturing: ELEVECTA™ 2.0 reshapes stable production economics
Cytiva | TBD | Emmanuelle Cameau; Timothy E. Erlandson; Michelle Hussong; Ines Do Carmo Goncalves |
| TBD | Poster | Successful technology transfer and scale-up of an established T flask adherent LVV process to an adherent bioreactor platform
Cytiva | TBD | Klaudia Kałuża, Holy Cross Cancer Center, Kielce, Poland |
| TBD | Poster | Synergizing Nanoplasmid vector technology and ELEVECTA™ transient cell line to improve AAV quality
Cytiva | TBD | Emmanuelle Cameau; Kerem Irfan; Carla Ruggiero; Tyler Kozisek; Vincent Dammai |
| TBD | Poster | Towards a universal lipid nanoparticle (LNP) platform for multiplex engineering of next- generation ex vivo cell therapies
Cytiva | TBD | Martin Rabel |
Integrated DNA Technologies has grown from an oligo manufacturer into a leading genomics provider, partnering with scientists and global health organizations to drive breakthroughs at scale. Guided by a commitment to advancing human health, we enable life-changing innovations from lab to life. IDT is Proud to be part of Danaher, we accelerate the impact of tomorrow’s science.
Aldevron provides critical nucleic acids and proteins used to make gene and cell therapies, gene editing technologies, DNA and RNA vaccines.
Beckman Coulter Life Sciences provides lab instruments, workflow automation, scientific insights, and service support for modern laboratories.

Beckman Coulter Life Sciences
OptiMATE Gradient Maker
• Transforms density gradient ultracentrifugation (DGUC) from a labor-intensive process into a streamlined, automated workflow for improved efficiency • Handles nearly all pre-centrifuge steps: gradient prep, precise dispensing and tube sealing • Significantly reduces errors and improves reproducibility for consistent results • Compatible with multiple tube types: Quick- Seal, OptiSeal and Open-Top tubes • Supports linear and step gradients for diverse experimental needs • Accelerates workflows by shortening run times up to 75% for linear gradients

Beckman Coulter Life Sciences
Vi-CELL BLU Cell Viability Analyzer
• Fully automated cell analysis platform for sample processing, viability assessment and cell counting using the trypan blue exclusion method • Delivers precise, reproducible measurements while minimizing operator variability • Automation reduces manual handling and ensures consistent data acquisition for critical decision-making in cell-based processes • Accelerate workflows with fast processing time (130 seconds per sample) • Ensure consistency with strong instrument-to-instrument correlation (+/- 10%) for optimal data comparison across labs and sites • Maximize flexibility with multiple loading options: 24-position carousel or 96-well plate

Beckman Coulter Life Sciences
CytoFLEX nano Flow Cytometer
The CytoFLEX nano Flow Cytometer is a pivotal development in flow cytometry that allows users to analyze extracellular vesicles (EVs) at least as small as 40 nm* with ease while simultaneously offering up to 6 separate fluorescent channels of detection and 5 side scatter channels, to deliver full characterization and open additional avenues for your nanoparticle research.